Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: Evidences from the National NCDs STEPS Survey, 2015

Yeweyenhareg Feleke Gebreyes, Dejuma Yadeta Goshu, Tedla Kebede Geletew, Terefe Gelibo Argefa, Theodros Getachew Zemedu, Kassahun Amenu Lemu, Feyissa Challa Waka, Alemayehu Bekele Mengesha, Fasil Shiferaw Degefu, Atkure Defar Deghebo, Habtamu Teklie Wubie, Mussie Gebremichael Negeri, Tefera Tadele Tesema, Yabetse Girma Tessema, Mulugeta Guta Regassa, Geremew Gonfa Eba, Misrak Getnet Beyene, Kissi Mudie Yesu, Girum Taye Zeleke, Yewondwossen Tadesse Mengistu, Abebe Bekele Belayneh, Yeweyenhareg Feleke Gebreyes, Dejuma Yadeta Goshu, Tedla Kebede Geletew, Terefe Gelibo Argefa, Theodros Getachew Zemedu, Kassahun Amenu Lemu, Feyissa Challa Waka, Alemayehu Bekele Mengesha, Fasil Shiferaw Degefu, Atkure Defar Deghebo, Habtamu Teklie Wubie, Mussie Gebremichael Negeri, Tefera Tadele Tesema, Yabetse Girma Tessema, Mulugeta Guta Regassa, Geremew Gonfa Eba, Misrak Getnet Beyene, Kissi Mudie Yesu, Girum Taye Zeleke, Yewondwossen Tadesse Mengistu, Abebe Bekele Belayneh

Abstract

The prevalence of diabetes, dyslipidemias, and high blood pressure is increasing worldwide especially in low and middle income countries. World Health Organization has emphasized the importance of the assessment of the magnitude of the specific disease in each country. We determined the prevalence and determinant factors of high blood pressure, hyperglycemia, dyslipidemias and metabolic syndrome in Ethiopia. A community based survey was conducted from -April to June 2015 using WHO NCD STEPS instrument version 3.1. 2008. Multistage stratified systemic random sampling was used to select representative samples from 9 regions of the country. A total of 10,260 people aged 15-69 years participated in the study. Blood pressure (BP) was measured for 9788 individuals. A total of 9141 people underwent metabolic screening. The prevalence of raised blood pressure (SBP ≥140 and/or DBP ≥ 90 mmHg) was 15.8% (16.3% in females and 15.5% in males). The prevalence of diabetes mellitus (FBS ≥ 126 mg /dl) including those on medication was 3.2% (3.5% males and 3.0% females). The prevalence of impaired fasting glucose was 9.1% with ADA criteria and 3.8% with WHO criteria. Hypercholesterolemia was found in 5.2%, hypertriglyceridemia in 21.0%, high LDL cholesterol occurred in 14.1% and low HDL cholesterol occurred in 68.7%. The prevalence of metabolic syndrome using IDF definition was 4.8% (8.6% in females and vs. 1.8% in males). Advanced age, urban residence, lack of physical exercise, raised waist circumference, raised waist hip ratio, overweight or obesity, and total blood cholesterol were significantly associated with raised blood pressure (BP) and diabetes mellitus. Increased waist- hip ratio was an independent predictor of raised blood pressure, hyperglycemia and raised total cholesterol. Our study showed significantly high prevalence of raised blood pressure, hyperglycemia and dyslipidemia in Ethiopia. Community based interventions are recommended to control these risk factors.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist. This is a subgroup analysis of our national data on WHO STEPS Survey, 2015.

Figures

Fig 1. Prevalence of dyslipidemia, WHO STEPS…
Fig 1. Prevalence of dyslipidemia, WHO STEPS survey, Ethiopia 2015.
Fig 2. Mean and SD values of…
Fig 2. Mean and SD values of total cholesterol, blood glucose, diastolic and systolic blood pressure, Ethiopia NCD steps, 2015.

References

    1. World Health Organization (2017) Non-Communicable Diseases, Fact sheet.
    1. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, et al. (2012) A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2224–2260. doi:
    1. Organization WH (2014) Global Status Report on Non-Communicable Diseases, World Health, 176.
    1. Alwan A, Maclean DR, Riley LM, d'Espaignet ET, Mathers CD, et al. (2010) Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet 376: 1861–1868. doi:
    1. World Health Organization (2013) Global action plan for the prevention and control of noncommunicable diseases 2013–2020.: Available from: .
    1. World Health Organization (2016) Global report on diabetes Swizerland, Geneva:WHO Press,.
    1. Ethiopian Federal Ministry of Health (2014) National Strategic Action Plan for Prevention and Control of Non Communicable Diseases in Ethiopia 2014–2016.
    1. Ethiopian Federal Ministry of Health (2016) National Comprehensive Guidelines for Clinical and Programmatic Management of Major Non-Communicable Diseases. 160–165.
    1. World Health Organization (2016) Ethiopia Steps Report on Risk Factors for Non-Communicable Diseaes and Prevalence of Selected NCDs Ethiopia Steps Report On Risk Factors For Chronic Non-Communicable Diseases.
    1. Ethiopian Federal Ministry of Health (2016) National Training guidelines on diabetes mellitus, hypertension Federal Democratic Republic of Ethiopia,: Ministry of Health.
    1. International Diabetes Federation (IDF) (2015) DIABETES ATLAS Seventh Edition 2015, International Diabetes Federation 144 p. p.
    1. World Health Organization (2009) Global Health Risks: Mortality and burden of disease attributable to selected major risks Bull World Health Organ; [Internet],. Available from: .
    1. World Health Organization (2014) Global status report on noncommunicable diseases: “Attaining the nine global noncommunicable diseases targets; a shared responsibility”; Italy, editor. Geneva, Switzerland: Second Press WHO.
    1. Kuller LH (2007) Epidemic hypertension in Sub-Saharan Africa. Hypertension 50: 1004–1005. doi:
    1. Addo J, Smeeth L, Leon DA (2007) Hypertension in sub-saharan Africa: a systematic review. Hypertension 50: 1012–1018. doi:
    1. Kibret KT, Mesfin YM (2015) Prevalence of hypertension in Ethiopia: a systematic meta-analysis. Public Health Reviews 36: 14 doi:
    1. Alemayehu CM, Birhanesilasie SK (2013) Assessment of stoke patients: occurrence of unusually high number of haemorrhagic stroke cases in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Clin Med Res 2: 94–100.
    1. Abdissa SG, Oli K, Feleke Y, Goshu DY, Begna DM, et al. (2014) Spectrum of cardiovascular diseases among Ethiopian patients at Tikur Anbessa Specialized University Teaching Hospital, Addis Ababa. Ethiop Med J 52: 9–17.
    1. Belayneh AB, Teklie H, Tadesse M, Defar A, Getachew T, et al. (2015) Pattern and trend of medical admissions of patients of chronic non-communicable diseases in selected Hospitals in Addis Ababa, Ethiopia. American Scientific Research Journal for Engineering, Technology, and Sciences (ASRJETS) 13: 34–48.
    1. Adediran Olufemi Sola OIC, Stephen Adeniyi Olasupo,Kayode Jimoh Ahmed, (2013) Hypertension prevalence in an Urban and Rural area of Nigeria. Journal of Medicine and Medical Sciences 4: 149–154.
    1. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, et al. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The lancet 364: 937–952.
    1. World Health Organization (2014) Overweight, Global health observatory:Deaths from NCDs.
    1. Tóth PP, Potter D, Ming EE (2012) Prevalence of lipid abnormalities in the united states: the national health and nutrition examination survey 2003–2006. Journal of clinical lipidology 6: 325–330. doi:
    1. Sun G-Z, Guo L, Wang X-Z, Song H-J, Li Z, et al. (2015) Prevalence of atrial fibrillation and its risk factors in rural China: a cross-sectional study. International journal of cardiology 182: 13–17. doi:
    1. Oguejiofor O, Onwukwe C, Odenigbo C (2012) Dyslipidemia in Nigeria: prevalence and pattern. Annals of African medicine 11: 197 doi:
    1. Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, et al. (2002) The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes care 25: 829–834.
    1. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, et al. (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes care 24: 683–689.
    1. Tesfaye F (2008) Epidemiology of cardiovascular disease risk factors in Ethiopia: the rural-ruban gradient: Epidemiologi och folkhälsovetenskap.
    1. Kishore J, Gupta N, Kohli C, Kumar N (2016) Prevalence of hypertension and determination of its risk factors in rural Delhi. International journal of hypertension.
    1. Ogah OS, Rayner BL (2013) Recent advances in hypertension in sub-Saharan Africa. Heart 99: 1390–1397. doi:
    1. Organization WH (2009) WHO STEPS Instrument for Chronic Disease. 1–12 p.
    1. Alberti G, Zimmet P, Shaw J, Grundy S International Diabetes Federation. The IDF consensus worldwide definition of the Metabolic Syndrome International Diabetes Fundation publication; 2006: 2–24.
    1. Organization WH (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation World Hearth Org.
    1. Roberts G, Tarivonda L, Bell C, Raj S, Latu R (2013) Vanuatu: NCD risk factors STEPs report.
    1. Ravikiran M, Bhansali A, Ravikumar P, Bhansali S, Dutta P, et al. (2010) Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey. Diabetes research and clinical practice 89: 181–188. doi:
    1. Zuo H, Shi Z, Hu X, Wu M, Guo Z, et al. (2009) Prevalence of metabolic syndrome and factors associated with its components in Chinese adults. Metabolism-Clinical and Experimental 58: 1102–1108. doi:
    1. Walia R, Bhansali A, Ravikiran M, Ravikumar P, Bhadada SK, et al. (2014) High prevalence of cardiovascular risk factors in Asian Indians: A community survey-Chandigarh Urban Diabetes Study (CUDS). The Indian journal of medical research 139: 252
    1. Mengesha AB (2015) Epidemiology of Preventable Risk Factors for Non-communicable Diseases among Adult Population in Tigray, Northern Ethiopia. [Dissertation]: Addis Ababa Univeristy.
    1. Tesfaye F, Nawi N, Van Minh H, Byass P, Berhane Y, et al. (2007) Association between body mass index and blood pressure across three populations in Africa and Asia. Journal of human hypertension 21: 28 doi:
    1. Franklin SS, Pio JR, Wong ND, Larson MG, Leip EP, et al. (2005) Predictors of new-onset diastolic and systolic hypertension: the Framingham Heart Study. Circulation 111: 1121–1127. doi:
    1. Franklin SS, Jacobs MJ, Wong ND, Gilbert J, Lapuerta P (2001) Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 37: 869–874.
    1. Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, et al. (2001) Does the relation of blood pressure to coronary heart disease risk change with aging?: The Framingham Heart Study. Circulation 103: 1245–1249.
    1. Muluneh AT, Haileamlak A, Tessema F, Alemseged F, Woldemichael K, et al. (2012) Population based survey of chronic non-communicable diseases at gilgel gibe field research center, southwest Ethiopia. Ethiopian journal of health sciences 22: 7–18.
    1. Anteneh ZA, Yalew WA, Abitew DB (2015) Prevalence and correlation of hypertension among adult population in Bahir Dar city, northwest Ethiopia: a community based cross-sectional study. International journal of general medicine 8: 175 doi:
    1. Abdissa SG, Feleke Y, Awol M (2015) Prevalence of hypertension and pre-hypertension in Addis Ababa, Ethiopia: A survey done in recognition of World Hypertension Day, 2014. The Ethiopian Journal of Health Development (EJHD) 29.
    1. Everett B, Zajacova A (2015) Gender differences in hypertension and hypertension awareness among young adults. Biodemography and social biology 61: 1–17. doi:
    1. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, et al. (2016) Global Disparities of Hypertension Prevalence and ControlClinical Perspective: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation 134: 441–450. doi:
    1. Dasappa H, Fathima FN, Prabhakar R, Sarin S (2015) Prevalence of diabetes and pre-diabetes and assessments of their risk factors in urban slums of Bangalore. Journal of family medicine and primary care 4: 399 doi:
    1. Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, et al. (2002) The Australian diabetes, obesity and lifestyle study (AusDiab)—methods and response rates. Diabetes research and clinical practice 57: 119–129.
    1. Ministry of Health Malawi and WHO (2009) Malawi National STEPS Survey for Chronic Non-Communicable Diseases and their Risk Factors. Final Report Ministry of Health,Malawi.
    1. Levitan EB, Song Y, Ford ES, Liu S (2004) Is nondiabetic hyperglycemia a risk factor for cardiovascular disease?: a meta-analysis of prospective studies. Archives of internal medicine 164: 2147–2155. doi:
    1. Balkau B, Bertrais S, Ducimetiere P, Eschwege E (1999) Is there a glycemic threshold for mortality risk? Diabetes care 22: 696–699.
    1. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, et al. (2000) The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes care 23: 1108–1112.
    1. Shaw JE, Zimmet PZ, Hodge AM, de Courten M, Dowse GK, et al. (2000) Impaired fasting glucose: how low should it go? Diabetes Care 23: 34–39.
    1. Garcez MR, Pereira JL, Fontanelli MdM, Marchioni DML, Fisberg RM (2014) Prevalence of dyslipidemia according to the nutritional status in a representative sample of Sao Paulo. Arquivos brasileiros de cardiologia 103: 476–484. doi:
    1. Joshi SR, Anjana RM, Deepa M, Pradeepa R, Bhansali A, et al. (2014) Prevalence of dyslipidemia in urban and rural India: the ICMR–INDIAB study. PloS one 9: e96808 doi:
    1. Okafor CI (2012) The metabolic syndrome in Africa: Current trends. Indian journal of endocrinology and metabolism 16: 56 doi:
    1. Tan BY, Kantilal HK, Singh R (2008) Prevalence of metabolic syndrome among Malaysians using the international diabetes federation, national cholesterol education program and modified World Health Organization definitions. Malaysian Journal of Nutrition 14: 65–77.
    1. Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, et al. (2000) Body mass index and the prevalence of hypertension and dyslipidemia. Obesity 8: 605–619.
    1. Gregg EW, Cheng YJ, Cadwell BL, Imperatore G, Williams DE, et al. (2005) Secular trends in cardiovascular disease risk factors according to body mass index in US adults. Jama 293: 1868–1874. doi:
    1. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, et al. (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116: 39–48. doi:

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner